The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?
Breast cancer is one of the leading malignant tumors that endanger women’s health worldwide. Despite the rapid progress on the therapies, including chemotherapy, surgical resection, and other auxiliary methods, there were still numerous people died of breast cancer, which promoted the researchers to...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-06-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317706214 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849416890943799296 |
|---|---|
| author | Qingqing Ou Jiang Cheng Licui Zhang Huimin Wang Wei Wang Yajing Ma |
| author_facet | Qingqing Ou Jiang Cheng Licui Zhang Huimin Wang Wei Wang Yajing Ma |
| author_sort | Qingqing Ou |
| collection | DOAJ |
| description | Breast cancer is one of the leading malignant tumors that endanger women’s health worldwide. Despite the rapid progress on the therapies, including chemotherapy, surgical resection, and other auxiliary methods, there were still numerous people died of breast cancer, which promoted the researchers to concentrate on the prognostic factor of breast cancer. In recent years, an increasing number of studies have been focused on the prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer. This article is a brief review of the associations between neutrophil-to-lymphocyte ratio and the prognosis of breast cancer patients, which may give a greater insight into the development of breast cancer and enable clinicians to cure it completely. |
| format | Article |
| id | doaj-art-07dc926a9c844a3dbd2a89550a9436c2 |
| institution | Kabale University |
| issn | 1423-0380 |
| language | English |
| publishDate | 2017-06-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Tumor Biology |
| spelling | doaj-art-07dc926a9c844a3dbd2a89550a9436c22025-08-20T03:33:02ZengSAGE PublishingTumor Biology1423-03802017-06-013910.1177/1010428317706214The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?Qingqing Ou0Jiang Cheng1Licui Zhang2Huimin Wang3Wei Wang4Yajing Ma5Medical College of Shihezi University, Shihezi, P.R. ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, P.R. ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, P.R. ChinaCollege of Life Sciences, Shihezi University, Shihezi, P.R. ChinaDepartment of Clinical Laboratory, Lianshui County People’s Hospital, Lianshui, P.R. ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, P.R. ChinaBreast cancer is one of the leading malignant tumors that endanger women’s health worldwide. Despite the rapid progress on the therapies, including chemotherapy, surgical resection, and other auxiliary methods, there were still numerous people died of breast cancer, which promoted the researchers to concentrate on the prognostic factor of breast cancer. In recent years, an increasing number of studies have been focused on the prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer. This article is a brief review of the associations between neutrophil-to-lymphocyte ratio and the prognosis of breast cancer patients, which may give a greater insight into the development of breast cancer and enable clinicians to cure it completely.https://doi.org/10.1177/1010428317706214 |
| spellingShingle | Qingqing Ou Jiang Cheng Licui Zhang Huimin Wang Wei Wang Yajing Ma The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? Tumor Biology |
| title | The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? |
| title_full | The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? |
| title_fullStr | The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? |
| title_full_unstemmed | The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? |
| title_short | The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? |
| title_sort | prognostic value of pretreatment neutrophil to lymphocyte ratio in breast cancer deleterious or advantageous |
| url | https://doi.org/10.1177/1010428317706214 |
| work_keys_str_mv | AT qingqingou theprognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT jiangcheng theprognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT licuizhang theprognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT huiminwang theprognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT weiwang theprognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT yajingma theprognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT qingqingou prognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT jiangcheng prognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT licuizhang prognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT huiminwang prognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT weiwang prognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous AT yajingma prognosticvalueofpretreatmentneutrophiltolymphocyteratioinbreastcancerdeleteriousoradvantageous |